Pure Global

Washed Microbiota Transplantation for Chronic Constipation in Adults - Trial NCT06106685

Access comprehensive clinical trial information for NCT06106685 through Pure Global AI's free database. This Phase 1/2 trial is sponsored by The Second Hospital of Nanjing Medical University and is currently Recruiting. The study focuses on Constipation. Target enrollment is 18 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06106685
Phase 1/2
Recruiting
drug
Trial Details
ClinicalTrials.gov โ€ข NCT06106685
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Washed Microbiota Transplantation for Chronic Constipation in Adults
Washed Microbiota Transplantation for Chronic Constipation in Adults: a Single-center, Randomized, Double-blind, Placebo-controlled, Dose-exploring Clinical Study

Study Focus

Constipation

High-dose washed microbiota suspension

Interventional

drug

Sponsor & Location

The Second Hospital of Nanjing Medical University

Nanjing,Nanjing, China

Timeline & Enrollment

Phase 1/2

Jul 24, 2023

Dec 01, 2026

18 participants

Primary Outcome

The incidence of treatment-related adverse events (AE) assessed by CTCAE, Version 5.0

Summary

This is a single-center, randomized, double-blind, placebo-controlled, dose-exploring
 clinical study to explore the safety and efficacy of washed microbiota transplantation (WMT)
 for patients with chronic constipation.

ICD-10 Classifications

Constipation
Irritable bowel syndrome with predominant constipation [IBS-C]
Other laxatives
Poisoning: Other laxatives
Other functional intestinal disorders

Data Source

ClinicalTrials.gov

NCT06106685

Non-Device Trial